Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor

The present invention relates to novel quinoline compounds of the formula (I) and to the salts thereof. The compounds possess valuable therapeutic properties and are particularly suitable, for treating diseases that respond to modulation of the serotonin 5-HT

Saved in:
Bibliographic Details
Main Authors TURNER, SEAN COLM, WICKE, KARSTEN, BRAJE, WILFRIED, HAUPT, ANDREAS, LANGE, UDO, DRESCHER, KARLA, UNGER, LILIANE, WERNET, WOLFGANG, MEZLER, MARIO, MAYRER, MATTHIAS
Format Patent
LanguageEnglish
Published 05.09.2013
Subjects
Online AccessGet full text

Cover

Loading…